ARCHIVES

Markison leaving Bristol-Myers, two others promoted in reorganization.

This article is from The Cancer Letter archive.

Vol. 30 No. 05 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

Progress Measures “Adequate,” Committee Says; Suggestions Include New Death Measure

August 12, 1988

Human Tissue Available Through NCI Network

July 10, 1987

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

Study: Routine CT Not Needed In Detecting DLBCL Remissions

May 31, 2013

ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market

January 24, 2003

NCI Tests Early Phase Study To Hasten Drug Development

August 31, 2007